Continued: since both arms of the Inflammation trial Include only patients who are HIV positive, it would be nice to screen for mutations before hand and afterwards to see what if any mutations emerged. I highly doubt that will be part of the trial design - Because it’s impact on HIV is not being measured. That’s all.